Morgan Stanley reduced its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 52.1% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 24,046 shares of the medical instruments supplier’s stock after selling 26,139 shares during the period. Morgan Stanley’s holdings in ICU Medical were worth $3,671,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the stock. Wellington Management Group LLP boosted its position in shares of ICU Medical by 12.1% in the first quarter. Wellington Management Group LLP now owns 652,897 shares of the medical instruments supplier’s stock valued at $99,697,000 after buying an additional 70,283 shares during the period. Wells Fargo & Company MN boosted its position in shares of ICU Medical by 29.3% in the first quarter. Wells Fargo & Company MN now owns 465,840 shares of the medical instruments supplier’s stock valued at $71,133,000 after buying an additional 105,570 shares during the period. Kennedy Capital Management Inc. boosted its position in shares of ICU Medical by 255.3% in the first quarter. Kennedy Capital Management Inc. now owns 120,547 shares of the medical instruments supplier’s stock valued at $18,408,000 after buying an additional 86,615 shares during the period. OppenheimerFunds Inc. boosted its position in shares of ICU Medical by 10.1% in the first quarter. OppenheimerFunds Inc. now owns 97,321 shares of the medical instruments supplier’s stock valued at $14,860,000 after buying an additional 8,936 shares during the period. Finally, Stifel Financial Corp boosted its position in shares of ICU Medical by 19.4% in the first quarter. Stifel Financial Corp now owns 84,324 shares of the medical instruments supplier’s stock valued at $12,871,000 after buying an additional 13,697 shares during the period. Hedge funds and other institutional investors own 77.10% of the company’s stock.

ICU Medical, Inc. (NASDAQ:ICUI) traded up 0.369% during trading on Thursday, reaching $170.225. The company’s stock had a trading volume of 20,975 shares. ICU Medical, Inc. has a 52 week low of $120.15 and a 52 week high of $176.50. The firm has a 50 day moving average of $171.81 and a 200 day moving average of $159.60. The stock has a market capitalization of $3.37 billion, a price-to-earnings ratio of 68.172 and a beta of 0.37.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by $0.06. ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The company had revenue of $331.51 million for the quarter, compared to the consensus estimate of $318.30 million. During the same quarter in the previous year, the firm posted $1.15 EPS. The business’s revenue for the quarter was up 242.8% compared to the same quarter last year. Analysts expect that ICU Medical, Inc. will post $4.11 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Morgan Stanley Sells 26,139 Shares of ICU Medical, Inc. (ICUI)” was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/08/17/morgan-stanley-sells-26139-shares-of-icu-medical-inc-icui.html.

Several equities analysts have issued reports on ICUI shares. Gabelli reiterated a “buy” rating on shares of ICU Medical in a research report on Friday, August 11th. Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $193.00 target price on the stock in a research report on Thursday, July 20th. Roth Capital cut ICU Medical from a “buy” rating to a “neutral” rating in a research report on Thursday, May 11th. They noted that the move was a valuation call. BidaskClub upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Saturday, June 17th. Finally, Sidoti cut ICU Medical from a “buy” rating to a “neutral” rating in a research report on Tuesday, June 20th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $193.00.

In other news, CFO Scott E. Lamb sold 23,772 shares of the business’s stock in a transaction dated Tuesday, July 11th. The shares were sold at an average price of $170.02, for a total transaction of $4,041,715.44. Following the transaction, the chief financial officer now owns 9,050 shares in the company, valued at approximately $1,538,681. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Robert S. Swinney sold 4,477 shares of the business’s stock in a transaction dated Thursday, July 20th. The stock was sold at an average price of $175.00, for a total transaction of $783,475.00. Following the transaction, the director now owns 23,293 shares in the company, valued at approximately $4,076,275. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 203,965 shares of company stock worth $34,856,920. Insiders own 15.90% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.